NCT06647173Completed
The Blued+ Combination HIV Prevention Pilot Study in China
Integrating a Combination HIV Prevention Intervention Into a Widely-Used Geosocial App for Chinese MSM: Pilot Study
Source: ClinicalTrials.gov · Last updated 16 Jul 2025
Brief summary (registry, in English)
The proposed research includes a longitudinal pilot study to assess the feasibility and acceptability of Blued+. This combination HIV prevention intervention will integrate a combination package of HIV prevention services into Blued, a gay dating App, for men who have sex with men (MSM) in China. Despite high HIV incidence among MSM, HIV prevention interventions such as pre-exposure prophylaxis (PrEP) use remains low in China. If the HIV prevention intervention services provided through the Blued+ App prove feasible and acceptable, the pilot test will facilitate the design of a larger study of intervention efficacy. The study population will be self-reported HIV-negative Blued users who are 18 years of age or greater, were assigned a male sex at birth, report having anal sex with a man in the last 6 months, eligible for PrEP according to China's consensus statement, and reside in metropolitan Beijing or Chengdu, China.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 423 (actual)
- First submitted
- 16 Oct 2024
- Start date
- Jul 2022
- Primary completion date
- Dec 2023
- Lead sponsor
- Emory University
- Diseases
- HIV
- NCT number
- NCT06647173
What you commit to
- Study type: Observational
- Participants enrolled: 423
- From Jul 2022 to the primary completion date, Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Has previously tested positive for HIV
Other illness
- Currently enrolled in another HIV prevention study
Age
- \<18 years of age
Other
- Not a registered Blued app user
- Not male sex at birth
- Does not report anal sex with a man in the last 6 months
- Not eligible for PrEP per published China guidance
- Unable to complete study instruments in Mandarin Chinese
- Not a resident of the metropolitan area of Beijing or Chengdu, China
- Evidence of fraudulent participation, such as a duplicate IP address, multiple screening attempts, duplicate emails, etc.
- Additional Inclusion criteria apply for PrEP
Who the study is looking for
- Registered Blued app user
- ≥18 years of age
- Male sex at birth
- Self-report anal sex with a man in the last 6 months
- HIV-negative or unknown HIV status
- Behaviorally eligible for PrEP per published China guidance
- Able to complete study instruments in Mandarin Chinese
- Resident of the metropolitan area of Beijing or Chengdu, China
- Eligible for PrEP based on China's consensus statement
- Additional Inclusion criteria apply for PrEP
Age in the registry: 18 years to - · Sex: Male · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| BlueD Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.